Fill-Finish & Packaging

Therapure acquires chromatography tech in Upfront deal

06-Dec-2013 By Dan Stanton

Technology firm Upfront Chromatography has exited the biopharmaceutical manufacturing market after selling its protein purification business to Therapure Biopharma.

DISPATCHES FROM CPhI

Cobra Biologics looks to reduce volume waste during fill/finish

23-Oct-2013 By Dan Stanton

A project to minimise the hold-up volume and losses in the fill/finish of biologics has reduced biologic waste ten-fold, says Cobra Biologics.

CMOs invest in fill/finish capacity in response to biopharma demand

11-Oct-2013 By Dan Stanton

Increasing interest in biopharmaceuticals has led to significant CMO investments and upgrades with Recipharm, Vetter and Aesica upping their fill/finish game this week.

US flu vaccine manufacturing network looks to increase capacity by 20%

04-Oct-2013 By Zachary Brennan

The US Department of Health and Human Services has awarded almost $40m (29m Euros) in contracts to four contract flu vaccine manufacturers as part of an effort to increase fill and finish capacity by 20%.

ATMI launches fill/finish pyrogene-free vials

27-Sep-2013

ATMI says its new line of vials for use in the downstream process is pyrogen-free and sterile upon delivery.

EMD Millipore: New chromatography offerings will meet industry need

20-Sep-2013 By Zachary Brennan

EMD Millipore on Tuesday launched a new protein A chromatography media to help biopharma manufacturers purify monoclonal antibodies, as well as new prepacked chromatography columns.

ATMI Invests in Medinstill Sterile Fill Tech

18-Sep-2013

Single-use biopharma provider ATMI has invested in sterile connector and fill technology developed by Medical Instill Technologies.

Sonoco Launches New 'Shippers' to Ensure Cold Chain

13-Sep-2013 By Dan Stanton

New European GDP guidance has led Sonoco to launch a series of shippers to store and transport biopharmaceuticals whilst ensuring an unbroken cold chain.

CMOs to Strengthen on Biopharma's Cytotoxic Demand, Report says

13-Sep-2013 By Dan Stanton

Cytotoxics will be a key growth opportunity for third-party manufacturers as biopharma increases its injectables outsourcing over the next few years, an industry report has predicted.

More Manufacturing Issues Lead to Alexion Recall

21-Aug-2013 By Dan Stanton

Alexion Pharma International has recalled a single lot of its monoclonal antibody (MAb) orphan drug Soliris due to the presence of visible particles in a limited number of vials.

XstalBio: New Tech Offers Speedier Biologic Reconstitution

16-Aug-2013 By Dan Stanton

XstalBio says its new technology reduces the time and increases the safety in reconstituting lyophilized biologics.

Technology News Is Vital for BioPharmas MIT Prof Tells BioPharma-Reporter.com

16-Jul-2013 By Gareth Macdonald

Keeping up with the latest technology news is a must for biomanufacturers according to an MIT Professor who told BioPharma-Reporter.com new advances in microtechnologies could help address process development challenges. 

ATMI Adds New Single-Use Fill/Finish Tech in Deal with CMO D-Lab

18-Apr-2013 By Gareth Macdonald

ATMI has started selling a new cGMP-compliant fill finish platform in a continuation of its focus on what it says is the growing single-use tech market.

PhaseBio says biopolymer delivery tech could cut insulin injections

31-Jan-2013 By Dan Stanton

Diabetes sufferers could be injecting insulin just once a week if a new drug delivery technique is picked up by a big pharma company.

Bosch makes liquid filling a disposable option

03-Apr-2008 By Phil Taylor

The use of disposable manufacturing equipment in pharmaceutical
production and greater need for containment equipment were
recurring themes at the Interphex show in Philadelphia last week,
and both were addressed by new equipment...